US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

The pharmaceutical industry is a $1 trillion-dollar sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.

  • Biopharmaceuticals (255)
  • Diseases & Conditions (4037)
  • Drug Delivery (285)
  • Therapeutic Area (7268)
  • Vaccines (721)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
The World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods), 6th Edition
7/16/2014 | published by: Kalorama Information
... with base year data for 2014, Clinical Nutrition Products: A Worldwide Perspective is a Kalorama Information report that focuses on three primary segments of essential medical nutrition: Infant Nutrition (Milk-based, Soy-based, Elemental, Follow-Up, Organic, Probiotic ...  |  read more...
USD 3,995
Croatia Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... withdrawals expected andthe HZZO braced for revolt from pharmacies and wholesalers. We forecast weak pharmaceutical marketgrowth over the next decade, in light of Croatia's acceding to EU pressure to rein in its budget deficit. Liquidity ...  |  read more...
USD 1,295
Mexico Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... Mexico will continueto undermine revenue-generating opportunities for innovative drugmakers. However, over the long term,healthier fiscal revenue due to energy reform will encourage the Mexican government to further increasepublic spending on medical services and improve national ...  |  read more...
USD 1,295
Zambia Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... to serve the district of Chienge. This,along with ongoing governmental training initiatives aimed at improving the skills of Zambian healthcareprofessionals, is likely to attract talent to the country. That said, speculation over President Sata's ill ...  |  read more...
USD 1,295
Alternative Medicines and Therapies in the United Kingdom
8/12/2014 | published by: Plimsoll Publishing Ltd.
... LTD and WELEDA (U K ) LTD. Covering activities such as seasonal affective disorder, herbs, sad light, herbal, sad and includes a wealth of information on the financial trends over the past four years. latest ...  |  read more...
USD 525
Pharmaceutical Wholesalers, Nordic Region
8/12/2014 | published by: Plimsoll Publishing Ltd.
... report (compiled in English language) includes a wealth of information on the financial trends over the past four years. latest Pharmaceutical Wholesalers Nordic analysis is perfect for investors to: See the market leaders Identify companies ...  |  read more...
USD 1,050
Pharmaceutical Wholesalers, Global
8/12/2014 | published by: Plimsoll Publishing Ltd.
... LTD.. This report includes a wealth of information on the financial trends over the past four years. latest Pharmaceutical Wholesalers Global analysis is perfect for investors to: See the market leaders Identify companies heading for ...  |  read more...
USD 1,425
Pharmaceutical Wholesalers in Europe
8/12/2014 | published by: Plimsoll Publishing Ltd.
... and UNITED DRUG PUBLIC LIMITED COMPANY. This report includes a wealth of information on the financial trends over the past four years. latest Pharmaceutical Wholesalers European analysis is perfect for investors to: See the market ...  |  read more...
USD 1,200
Global - Cancer Generics Market Outlook 2018
8/1/2014 | published by: RNCOS
... rising to almost 14.1 Million in 2012 and several blockbuster cancer drugs losing their patent protection, the market for cancer generics is bound to experience skyrocketing growth. According to our latest research report “Global Cancer ...  |  read more...
USD 1,400
Global - API Market Outlook 2018
8/1/2014 | published by: RNCOS
... for pharmaceuticals. However, major regulatory changes in the United States and Europe along with rising labor costs in China are set to change the API landscape. As patterns in developed regions continue to remain flat ...  |  read more...
USD 1,400
Bio-Rad Laboratories, Inc.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Allergic Rhinitis - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Herbalife LTD.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
McKesson Corporation: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Clinical Research in the United Kingdom
8/12/2014 | published by: Plimsoll Publishing Ltd.
... Covering activities such as clinical trials, cro, biotechnology, clinical research, pharmaceutical development and includes a wealth of information on the financial trends over the past four years. latest Clinical Research analysis is perfect for investors ...  |  read more...
USD 525
Medical Market Research in the United Kingdom
8/12/2014 | published by: Plimsoll Publishing Ltd.
... and ADELPHI GROUP LTD. Covering activities such as health, medical market research, kite, linguistic validation of a clinical trial questionnaire, occupational physiotherapy and includes a wealth of information on the financial trends over the past ...  |  read more...
USD 525
Chemists and Pharmacies in Europe
8/12/2014 | published by: Plimsoll Publishing Ltd.
... CO-OP HEALTH CARE LIMITED. This report includes a wealth of information on the financial trends over the past four years. latest Chemists & Pharmacies European analysis is perfect for investors to: See the market leaders ...  |  read more...
USD 1,200
Vital Signs - Healthcare News - The Analyst's Perspective - July Issue
8/4/2014 | published by: Frost & Sullivan
... the FDA to take prompt action in releasing draft guidance on LDTs so that there can be efficient policing of diagnostic tools before being released into the market. The Analyst’s Perspective by Aish Vivekanandan, Industry ...  |  read more...
USD 450
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland
8/12/2014 | published by: GlobalData
... and analysis, identifies key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscapes and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the ...  |  read more...
USD 1,995
Arteriosclerosis Global Clinical Trials Review, H2, 2014
8/12/2014 | published by: GlobalData
... relating to the clinical trials on Arteriosclerosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Atrial Septal Defect Global Clinical Trials Review, H2, 2014
8/12/2014 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Atrial Septal Defect. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
Aspen Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
AstraZeneca Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
USD 995
Cardiomyopathy Global Clinical Trials Review, H2, 2014
8/12/2014 | published by: GlobalData
... relating to the clinical trials on Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Medullary Thyroid Cancer - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Medullary Thyroid Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
< prev 1    3  4  5  6  7  8  9  10